A new pathway that is used by cancer cells to infiltrate the brain has been discovered by a team of Canadian and American research groups led by the Singh Lab at McMaster University.
FDA grants priority review for Zealand Pharma’s dasiglucagon
Dasiglucagon is intended for usage in infants aged seven days and above with congenital hyperinsulinism. Credit: Liudmila Fadzeyeva / Shutterstock.com. The US Food and Drug